loading
전일 마감가:
$2.42
열려 있는:
$2.42
하루 거래량:
79,167
Relative Volume:
0.50
시가총액:
$3.18M
수익:
-
순이익/손실:
$-4.74M
주가수익비율:
-4.0611
EPS:
-0.6476
순현금흐름:
$-3.46M
1주 성능:
+8.36%
1개월 성능:
-30.93%
6개월 성능:
-49.11%
1년 성능:
-70.11%
1일 변동 폭
Value
$2.42
$2.70
1주일 범위
Value
$2.31
$2.75
52주 변동 폭
Value
$2.21
$12.00

Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile

Name
명칭
Lipella Pharmaceuticals Inc
Name
전화
412-901-0315
Name
주소
400 N LEXINGTON ST, PITTSBURGH
Name
직원
7
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
LIPO's Discussions on Twitter

LIPO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
LIPO 2.63 3.18M 0 -4.74M -3.46M -0.6476
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스

pulisher
12:30 PM

Lipella Pharmaceuticals completes dosing for first cohort in LP-310 trial - MSN

12:30 PM
pulisher
Nov 21, 2024

Lipella Pharmaceuticals Announces Completion of First - GlobeNewswire

Nov 21, 2024
pulisher
Nov 21, 2024

Lipella's LP-310 OLP Treatment Advances in Phase 2a Trial with Promising Safety Data | LIPO Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN

Nov 20, 2024
pulisher
Nov 17, 2024

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023) - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

LIPO stock touches 52-week low at $2.21 amid market challenges - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Lipella Pharmaceuticals Inc (LIPO) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Lipella Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Lipella issued patent by USPTO for liposomal drug delivery platform - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharma Secures Key Patent for Liposomal Platform, Extends Drug Pipeline Protection to 2035 | LIPO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

China chip index nears 3-year high as TSMC order fuels self-reliance bets - Investing.com

Nov 11, 2024
pulisher
Nov 08, 2024

Cathay general bancorp vice chairman sells $2.11 million in stock - Investing.com

Nov 08, 2024
pulisher
Nov 06, 2024

Contrasting Wellness Center USA (OTCMKTS:WCUI) & Lipella Pharmaceuticals (NASDAQ:LIPO) - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 03, 2024

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split - citybiz

Nov 03, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals Launching 1-for-8 Reverse Stock Split - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Oct 29, 2024

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference - GlobeNewswire

Oct 29, 2024
pulisher
Oct 19, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Oct 18, 2024
pulisher
Oct 16, 2024

Ocugen Inc (OCGN) rating initates by Maxim Group - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Potential Price Increase for First Advantage Corp. (FA) After Recent Insider Activity - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Lipella Pharmaceuticals Inc (LIPO) Becoming More Attractive for Investors - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Recent Insider Activity Suggests Potential Gains for KE Holdings Inc ADR (BEKE) - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Lipella Pharmaceuticals Inc [LIPO] is -57.84% lower this YTD. Is it still time to buy? - The DBT News

Oct 16, 2024
pulisher
Oct 15, 2024

Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com

Oct 15, 2024
pulisher
Oct 15, 2024

Huge semiconductor deal has eyes on this tech co 👀 - RagingBull

Oct 15, 2024
pulisher
Oct 15, 2024

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform - GlobeNewswire

Oct 15, 2024
pulisher
Oct 13, 2024

Interstitial Cystitis Market Size is Set for Rapid Growth as - openPR

Oct 13, 2024
pulisher
Oct 09, 2024

Sky Quarry Announces Closing of Public Offering of $6.7 Million - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 09, 2024

Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024
pulisher
Sep 30, 2024

Expion360 Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 26, 2024

Insider Buying: Kaufman Jonathan H, Lipella Pharmaceuticals Inc [LIPO] insider invested 10,000 shares - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

The time has not yet come to remove your chips from the table: Lipella Pharmaceuticals Inc (LIPO) - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

Lipella Pharmaceuticals Inc Inc. (LIPO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month - Morningstar

Sep 25, 2024
pulisher
Sep 24, 2024

Lipella reports positive phase 2a trial results for OLP treatment - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Lipella Pharmaceuticals Reports Encouraging Early - GlobeNewswire

Sep 24, 2024

Lipella Pharmaceuticals Inc (LIPO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
자본화:     |  볼륨(24시간):